Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nuno Cortez-Dias , Fausto J Pinto Added: 3 years ago
Coronary artery disease (CAD) represents the leading cause of morbidity and mortality in western countries. Many non-invasive stress tests are currently available for detecting CAD and assessing prognosis. Non-invasive stress techniques comprise exercise electrocardiographic (ECG) stress testing and imaging techniques, namely exercise/pharmacological stress echocardiography (SEcho) and exercise… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
Author(s): Eric HC Yu Added: 3 years ago
Contemporary approved echo contrast agents share a common approved indication of left ventricular opacification and enhancement of endocardial border delineation for the assessment of left ventricular function in patients with technically suboptimal echocardiograms (ECGs). The use of echo contrast agents with advanced imaging technologies has resulted in the conversion of many non-diagnostic ECGs… View more

Imaging & Diagnostics
Author(s): Clyde W Yancy Added: 3 years ago
The US population is characterized by significant racial/ethnic demographic transitions with an emerging number of special populations at risk for cardiovascular disease. Amongst the special populations with heart disease, it is heart failure in African-Americans that has become the prototypical model. Heart FailureÔÇöAn Enigmatic Disease in African-Americans Chronic heart failure is no longer… View more

Heart Failure
HF 2022: Heart Failure Highlights of 2022 with Prof Cleland
Author(s): John GF Cleland Added: 1 year ago
Prof John Cleland (University of Glasgow & Glasgow Royal Infirmary, Glasgow, UK) joined us to talk about heart failure management highlights in 2022 including a new phenotype, HFsnEF; available and new treatment options; news on SGLT2is and more. Recorded at Heart Failure 2022, Madrid. Videographer: Tom Green Editor: Mirjam Boros View more

Standards & Guidelines

Heart Failure
Author(s): Tasneem Z Naqvi Added: 3 years ago
Congestive heart failure (CHF) is the number one hospital discharge diagnosis for older adults and the leading cause of hospital readmissions, reflecting poor quality of life for patients and increased healthcare resource use, and is the cause of 300,000 deaths annually.1 Cardiac resynchronization therapy (CRT) has become a new effective treatment modality in those with drug-resistant advanced… View more

Heart Failure

Electrophysiology & Arrhythmia
Percutaneous Coronary Intervention for Chronic Total Occlusion
Author(s): Giovanni Maria Vescovo , Carlo Zivelonghi , Benjamin Scott , et al Added: 3 years ago
Coronary chronic total occlusion (CTO), defined as complete occlusion of a coronary artery for at least 3 months with thrombolysis in myocardial infarction (TIMI) grade 0 flow, represents one of the most complex situations in the field of interventional cardiology.1 Despite an incidence of CTO in patients with stable coronary artery disease (CAD) undergoing coronary angiography of 18–46%, the… View more

Intervention
Author(s): Maria Rosa Costanzo Added: 3 years ago
In the US, 90% of the one million annual hospitalizations for heart failure (HF) are due to volume overload.1,2 Hypervolemia contributes to HF progression and mortality. Guidelines recommend that therapy for HF patients be aimed at achieving euvolemia. Intravenous loop diuretics induce rapid diuresis that reduces lung congestion and dyspnea. However, the effectiveness of loop diuretics declines… View more

Heart Failure
Author(s): Rebecca L Attridge , Rebecca D Moote , Deborah J Levine Added: 3 years ago
Pulmonary hypertension is classified into five groups by the World Health Organization (WHO). Group 1, pulmonary arterial hypertension (PAH), is a progressive disease characterized by an elevation in pulmonary arterial pressure and pulmonary vascular resistance that may progress to right heart dysfunction and failure.1 PAH is defined as a mean pulmonary artery pressure (mPAP) ≥25 mmHg at rest,… View more

Heart Failure

Prevention & Chronic Conditions
Author(s): Jorge Silva Enciso , Eric Adler , Barry H Greenberg Added: 3 years ago
Advanced heart failure (AHF) affects approximately 5–10 % of the current 6.6 million people living with heart failure, having a higher incidence in those above 65 years of age.1 The presence of the disease is associated with 50–80 % mortality at 1 year, indicating the need for innovative therapies to manage the burden of this disease. Heart transplantation is the gold standard for AHF, although… View more

Heart Failure
Author(s): Marti L McCulloch , Robert J Davis Added: 3 years ago
The cardiac imaging field has experienced significant improvements over the last decade due to technological advances. Cardiac computed tomography (CT), cardiac magnetic resonance imaging (MRI), nuclear cardiology, and echocardiography have all become feasible imaging modalities for physicians to evaluate in order to answer specific diagnostic questions. Each of the aforementioned modalities has… View more

Standards & Guidelines

Imaging & Diagnostics